Rare Disease Therapeutics
Pharming news and milestones
Pharming: 12 headlines on record, 8 headlines in the last 90 days.
Data updated Nov 13, 2026 · Back to the company report
12Headlines
8In 90 days
0Milestones
Headlines
Oct 62026
News · pharmexec.com
New U.S. guidance carves out tariff exemptions for specialty pharmaceuticals, Pharming
Oct 62026
News · pharmexec.com
Pharming CEO Fabrice Chouraqui has stepped down amid strategic disagreements with the board, with chief commercial officer Leverne Marsh and chief financial officer Kenneth Lynar…
Sep 302026
News · seekingalpha.com
Sep 292026
News · YahooFinance
Leiden, the Netherlands, September 29, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today…
Sep 292026
News · marketwatch.com
Sep 292026
News · FinanzNachrichten.de
Leiden, the Netherlands, September 29, 2026,Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR), a global biotechnology company focused on rare immune and genetic diseases, today a…
Sep 252026
News · FinanzNachrichten.de
If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or moreDecision follows recent approval of Joenja for children aged 4…
Sep 172026
News · YahooFinance
Pharming Group N.V. (NASDAQ:PHAR) announced on September 11 that the U.S. Food and Drug Administration approved Joenja for children aged 4-11 with activated PI3K delta syndrome,…
Oct 14, 20242024
News · nasdaq.com
News · vanlanschotkempen.com
We are your one-stop shop with top-tier international expertise and a global investor network.
News · rbccm.com
News · canaccordgenuity.com
Sources: the outlets named on each headline, each story once
How to cite
Pharming, News. Alion, Nov 13, 2026. https://alion.io/company/pharming/news